Study Summary
This trial will test whether practice facilitation can help improve the fidelity of an intervention and clinical measures.
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 2 Secondary · Reporting Duration: 12 months
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Usual Care
1 of 2
Practice Faciliation
1 of 2
Active Control
Experimental Treatment
700 Total Participants · 2 Treatment Groups
Primary Treatment: ALTA · No Placebo Group · Phase 4
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 90 · All Participants · 7 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:- Schoenthaler, Antoinette, Franzenith De La Calle, Amanda Soto, Derrel Barrett, Jocelyn Cruz, Leydi Payano, Marina Rosado, Samrachana Adhikari, Gbenga Ogedegbe, and Milagros Rosal. 2021. “Bridging the Evidence-to-practice Gap: A Stepped-wedge Cluster Randomized Controlled Trial Evaluating Practice Facilitation as a Strategy to Accelerate Translation of a Multi-level Adherence Intervention into Safety Net Practices”. Implementation Science Communications. Springer Science and Business Media LLC. doi:10.1186/s43058-021-00111-2.
- Schoenthaler, Antoinette, Franzenith De La Calle, Amanda Soto, Derrel Barrett, Jocelyn Cruz, Leydi Payano, Marina Rosado, Samrachana Adhikari, Gbenga Ogedegbe, and Milagros Rosal. 2021. “Bridging the Evidence-to-practice Gap: A Stepped-wedge Cluster Randomized Controlled Trial Evaluating Practice Facilitation as a Strategy to Accelerate Translation of a Multi-level Adherence Intervention into Safety Net Practices”. Implementation Science Communications. Springer Science and Business Media LLC. doi:10.1186/s43058-021-00111-2.
- Schoenthaler A, De La Calle F, Soto A, Barrett D, Cruz J, Payano L, Rosado M, Adhikari S, Ogedegbe G, Rosal M. Bridging the evidence-to-practice gap: a stepped-wedge cluster randomized controlled trial evaluating practice facilitation as a strategy to accelerate translation of a multi-level adherence intervention into safety net practices. Implement Sci Commun. 2021 Feb 17;2(1):21. doi: 10.1186/s43058-021-00111-2. Erratum In: Implement Sci Commun. 2021 Oct 21;2(1):122.
- 2020. "Bridging the Evidence-to-practice Gap". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03713515.
Frequently Asked Questions
Is the minimum age requirement for this research project younger than twenty years old?
"This trial is seeking volunteers who are of legal age and under 90 years old." - Anonymous Online Contributor
Has the Federal Drug Administration authorized ALTA for utilization?
"Since ALTA has already been approved, there is a high degree of confidence in its safety; thus it earned a score of 3." - Anonymous Online Contributor
Is participation in this experiment available to me?
"This research initiative is seeking 700 individuals with hypertension aged 18-90. The primary prerequisites for eligibility are: participants must be prescribed one or more antihypertensive medications and have exhibited <80% adherence to the prescriptions in the last year, as per pharmacy records obtained from their healthcare provider's electronic health record system; they must also exceed the age of majority." - Anonymous Online Contributor
Are individuals being enlisted for the experiment at this time?
"Affirmative. Clinicaltrials.gov affirms that this clinical trial, first uploaded on December 1st 2020, is actively looking for participants. Approximately 700 people must be enrolled from a single healthcare facility to complete the study." - Anonymous Online Contributor
Is there a cap on the number of participants in this medical research project?
"Indeed, clinicaltrials.gov verifies that this research study is still recruiting participants for participation. The trial was posted on December 1st 2020 and recently modified on November 8th 2022; 700 patients are required from one medical site to complete the experiment." - Anonymous Online Contributor